All jobs

About Xenon Pharmaceuticals Inc.

Biotechnology Research · Canada

Website

About Xenon Pharmaceuticals Inc.

A neuroscience-focused biopharmaceutical company

Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
Burnaby, BC
Company type
Public Company

Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. Our lead molecule, azetukalner, is a novel, potent, selective Kv7 potassium channel opener in Phase 3 clinical trials for the treatment of epilepsy, major depressive disorder (MDD) and bipolar depression (BPD). We are also advancing an early-stage portfolio of multiple promising potassium and sodium channel modulators, including Kv7 and Nav1.7 programs in Phase 1 development for the potential treatment of pain. We have offices in Vancouver, British Columbia, and Boston, Massachusetts.

Specialties

  • biotechnology
  • ion channel science
  • neurology
  • epilepsy
  • depression
  • and pain

Company locations

  • 3650 Gilmore Way, Burnaby, BC V5G 4W8, CA

  • 117 Kendrick Street, Suite 200, Needham, MA 02494, US

Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.

On LinkedIn

Followers
29,831
People linked to this company
432

People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.

Employer category

Other employer

Estimated from the company profile. This category has not been confirmed by the employer.

Get in touch
MovoJobs

How can we help?